Erratum: Anti-tumor activity of a novel compound-CDF is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer (PLoS ONe (2011) 6:3(e17850)DOI: 10.1371/journal.pone.0017850);Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and pten in pancreatic cancer

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Bao, Bin ^a   Ali, Shadan ^b   Kong, Dejuan ^a   Sarkar, Sanila H ^a   Wang, Zhiwei ^a   Banerjee, Sanjeev ^a   Aboukameel, Amro ^b   Padhye, Subhash ^c   Philip, Philip A ^b   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c DR DY PATIL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; CYCLOOXYGENASE 2; DIFLUORINATED CURCUMIN; EPITHELIAL CELL ADHESION MOLECULE; GEMCITABINE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 200; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; VASCULOTROPIN; CELL ADHESION MOLECULE; DEOXYCYTIDINE; DRUG DERIVATIVE; MESSENGER RNA; MIRN200 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR PROTEIN; TUMOR-ASSOCIATED ANTIGEN GA733;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN DNA BINDING; SCID MOUSE; TUMOR XENOGRAFT; ANIMAL; CANCER INVASION; CELL AGGREGATION; CELL CLONE; CELL PROLIFERATION; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL ADHESION MOLECULES; CELL AGGREGATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CLONE CELLS; CURCUMIN; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NF-KAPPA B; PANCREATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79952382550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0205300     Document Type: Erratum

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Gaviraghi M, Tunici P, Valensin S, Rossi M, Giordano C, et al. (2010) Pancreatic cancer spheres are more than just aggregates of stem marker positive cells. Biosci Rep.
3. Hermann PC, Bhaskar S, Cioffi M, Heeschen C, (2010) Cancer stem cells in solid tumors. Semin Cancer Biol 20: 77-84.
4. Ischenko I, Seeliger H, Kleespies A, Angele MK, Eichhorn ME, et al. (2010) Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications. Langenbecks Arch Surg 395: 1-10.
5. Lee CJ, Dosch J, Simeone DM, (2008) Pancreatic cancer stem cells. J Clin Oncol 26: 2806-2812.
6. Mueller MT, Hermann PC, Heeschen C, (2010) Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front Biosci (Elite Ed) 2: 602-613.
7. Abas F, Lajis NH, Shaari K, Israf DA, Stanslas J, et al. (2005) A labdane diterpene glucoside from the rhizomes of Curcuma mangga. J Nat Prod 68: 1090-1093.
8. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV, (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652.
9. Narayan S, (2004) Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways. J Mol Histol 35: 301-307.
10. Padhye S, Banerjee S, Chavan D, Pandye S, Swamy KV, et al. (2009) Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice. Pharm Res 26: 2438-2445.
11. Padhye S, Yang H, Jamadar A, Cui QC, Chavan D, et al. (2009) New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharm Res 26: 1874-1880.
12. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, et al. (2010) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 70: 3606-3617.
13. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
14. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M, (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12: 2171-2176.
15. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
16. Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, et al. (2003) Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22: 3243-3251.
17. Sebens S, Arlt A, Schafer H, (2008) NF-kappaB as a molecular target in the therapy of pancreatic carcinoma. Recent Results Cancer Res 177: 151-164.
18. Zhang Z, Rigas B, (2006) NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review). Int J Oncol 29: 185-192.
19. Liu S, Dontu G, Wicha MS, (2005) Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 7: 86-95.
20. Sarkar FH, Li Y, Wang Z, Kong D, (2009) Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64: 489-500.
21. Creighton CJ, Chang JC, Rosen JM, (2010) Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15: 253-260.
22. Li Y, Kong D, Wang Z, Sarkar FH, (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res 27: 1027-1041.
23. Sarkar FH, Li Y, Wang Z, Kong D, Ali S, (2010) Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13: 57-66.
24. Li Y, Vandenboom TG, Wang Z, Kong D, Ali S, et al. (2010) miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70: 1486-1495.
25. Vandenboom Ii TG, Li Y, Philip PA, Sarkar FH, (2008) MicroRNA and Cancer: Tiny Molecules with Major Implications. Curr Genomics 9: 97-109.
26. Krichevsky AM, Gabriely G, (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53.
27. Shimosegawa T, Kume K, Satoh K, (2009) Chronic pancreatitis and pancreatic cancer: prediction and mechanism. Clin Gastroenterol Hepatol 7: S23-S28.
28. Bunney TD, Katan M, (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 10: 342-352.
29. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, et al. (2009) miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27: 1712-1721.
30. Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, et al. (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69: 6704-6712.
31. Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, et al. (2010) FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharm Res 27: 1159-1168.
32. Chou TC, Talalay P, (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
33. Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, et al. (2009) Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl Oncol 2: 321-328.
34. El-Rayes BF, Ali S, Sarkar FH, Philip PA, (2004) Cyclooxygenase-2-dependent and-independent effects of celecoxib in pancreatic cancer cell lines. Mol Cancer Ther 3: 1421-1426.